- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
A genetic variant of FcγRIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer - Abstract
February 13, 2013
Touch imprint cytology of prostate core needle biopsy specimens: A useful method for immediate reporting of prostate cancer - Abstract
February 13, 2013
Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer - Abstract
February 13, 2013
Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model - Abstract
February 13, 2013
Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo - Abstract
February 11, 2013
Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome - Abstract
February 11, 2013
Adenosine receptor antagonism suppresses functional and histological inflammatory changes in the rat urinary bladder - Abstract
February 11, 2013
NS309 decreases rat detrusor smooth muscle membrane potential and phasic contractions by activating SK3 channels - Abstract
February 11, 2013
Common variants in mismatch repair genes associated with increased risk of sperm DNA damage and male infertility - Abstract
February 11, 2013
Expression of stem-cell markers OCT-4 and CD133: Important prognostic factors in papillary renal cell carcinoma - Abstract
February 9, 2013
A case-control study of peripheral blood mitochondrial DNA copy number and risk of renal cell carcinoma - Abstract
February 9, 2013
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data - Abstract
February 9, 2013
Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D - Abstract
February 9, 2013
MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway - Abstract
February 9, 2013